A study by the Union Health Ministry and global health organisations found that introducing the Hexavalent (six-in-one) vaccine in India’s Universal Immunisation Programme (UIP) could improve vaccination efficiency.
The Hexavalent vaccine protects against six diseases — Diphtheria, Tetanus, Pertussis (whooping cough), Hepatitis B, Haemophilus influenzae type b (Hib), and Polio.
It can reduce the number of injections required for infants, decrease the workload of health workers, and reduce cold-chain management needs.
India vaccinates around 26 million infants annually, and the current system requires multiple vaccine doses during visits.
The study found that although the vaccine may have higher initial costs, reducing its price could result in overall savings for the government and households.
The vaccine could simplify India’s immunisation programme by replacing the existing Pentavalent vaccine and Fractional Inactivated Polio Vaccine (IPV) doses in future policy decisions.